Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: The NCAN-PNPLA3-lipid connection?

Journal of Hepatology

Volumn 61, Issue 5, 2014, Pages 971-972

  Nault, Jean Charles ^a,b,c   Nahon, Pierre ^a,b,c  

^a HÔPITAL JEAN VERDIER   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LECTIN; NERVE PROTEIN; PROTEOCHONDROITIN SULFATE;

ALCOHOL LIVER CIRRHOSIS; EDITORIAL; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NCAN GENE; PNPLA3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ALCOHOL LIVER DISEASE; CARCINOMA, HEPATOCELLULAR; COMPLICATION; FEMALE; GENETICS; LIVER NEOPLASMS; MALE;

CARCINOMA, HEPATOCELLULAR; CHONDROITIN SULFATE PROTEOGLYCANS; FEMALE; HUMANS; LECTINS, C-TYPE; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; NERVE TISSUE PROTEINS;

EID: 84933505439     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.001     Document Type: Editorial

References (20)

1. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: The role of polymorphisms in candidate genes. JAMA 2008;299: 2423-2436.
2. Nahon P, Zucman-Rossi J. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. J Hepatol 2012;57: 663-674.
3. Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, et al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 2009;50: 1484-1493.
4. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380: 2224-2260.
5. Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007;109: 2490-2496.
6. McGivern DR, Lemon SM. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 2011;30: 1969-1983.
7. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-Alcoholic fatty liver disease: An emerging menace. J Hepatol 2012;56: 1384-1391.
8. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127: S87-S96.
9. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7: 763-777.
10. Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol 2009;50: 1132-1141.
11. Trepo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, et al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-Analysis of individual participant data. Hepatology 2014;59: 2170-2177.
12. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011;7: E1001324.
13. Gorden A, Yang R, Yerges-Armstrong LM, Ryan KA, Speliotes E, Borecki IB, et al. Genetic variation at NCAN locus is associatedwith inflammation and fibrosis in non-Alcoholic fatty liver disease inmorbid obesity.HumHered 2013;75: 34-43.
14. Nischalke HD, Lutz P, Kramer B, Sohne J, Muller T, Rosendahl J, et al. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J Hepatol 2014;61: 1073-1079.
15. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008;40: 189-197.
16. Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjaerg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2014;46: 352-356.
17. Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-Alcoholic fatty liver disease. Nat Commun 2014;5: 4309.
18. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012;44: 694-698.
19. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011;43: 1210-1214.
20. Reeves GK, Travis RC, Green J, Bull D, Tipper S, Baker K, et al. Incidence of breast cancer and its subtypes in relation to individual and multiple lowpenetrance genetic susceptibility loci. JAMA 2010;304: 426-434.